본문 바로가기
KERD
논문KCI 등재

Fetal Alveolar Type II Cell Injury Induced by Short-term Exposure to Hyperoxia

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

A High concentration of oxygen (>40%) is used as a life-saving therapy in preterm newborns since birth. By generating excess reactive oxygen species, however,hyperoxia can cause lung injury leading to bronchopulmonary dysplasia (BPD). Although hyperoxia-induced lung injury contributes to the evolution of BPD,the mechanisms by which hyperoxia contributes to the genesis of lung injury in preterm lungs are not yet fully defined, and there are no specific measures for the protection of preterm lungs against injury secondary to hyperoxia. Alveolar type II cells are key components of the alveolar structure, and they are responsible for the restoration of normal alveolar epithelium after acute lung injury. However,hyperoxia is primarily delivered to the alveolar epithelium and alveolar type II cells can be the main target for the injury secondary to hyperoxia. To date, my researches have been focused on injury of fetal alveolar type II cells exposed to hyperoxia and the role of anti-inflammatory cytokine, IL-10 minimizing fetal type II cell injury induced by hyperoxia. Based on my previous studies, this article summarizes the cellular and molecular mechanisms of fetal type II cell injury induced in the early stage of hyperoxia and the protective potency of IL-10 in fetal alveolar type II cells and neonatal lungs injured by hyperoxia.

Abstract

A High concentration of oxygen (>40%) is used as a life-saving therapy in preterm newborns since birth. By generating excess reactive oxygen species, however,hyperoxia can cause lung injury leading to bronchopulmonary dysplasia (BPD). Although hyperoxia-induced lung injury contributes to the evolution of BPD,the mechanisms by which hyperoxia contributes to the genesis of lung injury in preterm lungs are not yet fully defined, and there are no specific measures for the protection of preterm lungs against injury secondary to hyperoxia. Alveolar type II cells are key components of the alveolar structure, and they are responsible for the restoration of normal alveolar epithelium after acute lung injury. However,hyperoxia is primarily delivered to the alveolar epithelium and alveolar type II cells can be the main target for the injury secondary to hyperoxia. To date, my researches have been focused on injury of fetal alveolar type II cells exposed to hyperoxia and the role of anti-inflammatory cytokine, IL-10 minimizing fetal type II cell injury induced by hyperoxia. Based on my previous studies, this article summarizes the cellular and molecular mechanisms of fetal type II cell injury induced in the early stage of hyperoxia and the protective potency of IL-10 in fetal alveolar type II cells and neonatal lungs injured by hyperoxia.

참고문헌 (60)

  1. Jobe AH, "Mechanisms initiating lung injury in the preterm", Early Hum Dev, 53, pp.81~94 (1998)
  2. Ehrenkrnnz RA, "Validation of the national institute of health consensus definition of bronchopulmonary dysplasia", Pediatrics, 116, pp.1353~1360 (2005)
  3. Lee PJ, "Serial review: Role of reactive oxygen and nitrogen species (ROS", RNS) in lung injury and diseases, 2003, pp.35, 341~350
  4. Speer CP, "Inflammation and bronchopulmonary dysplasia: a continuing story", Semin Fetal Neonatal Med, 11, pp.354~362 (2006)
  5. Jeyaseelan S, "Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium", Am J Respir Cell Mol Biol, 32, pp.531~539 (2005)
  6. Mallampalli RK, "Differentiation of the alveolar epithelium in the fetal lung, In Lung growth and development", pp.119~162 (1997), Marcel Dekker
  7. Yee M, "Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung developmemt", Am J Physiol Lung Cell Mol Physiol, 291, pp.L1101~L1111 (2006)
  8. Garingo A, "Constitutive IL-10 expression by lung inflammatory cells and risk for bronchopulmonary dysplasia", Pediatr Res, 61, pp.197~202 (2007)
  9. Mantell LL, "Signal transduction pathways in hyperoxiainduced lung cell death", Mol Genet Metab, 71, pp.359~370 (2000)
  10. Gerschman R, "Oxygen poisoning and x-irradiation: a mechanism in common", Science, 119, pp.623~626 (1954)
  11. Ischiropoulos H, "Peroxynitrite-mediated oxidative protein modifications", FEBS Lett, 364, pp.279~282 (1995)
  12. Janssen YM, "Cell and tissue responses to oxidative damage", Lab Invest, 69, pp.261~274 (1993)
  13. Ueda N, "Endonuclease-induced DNA damage and cell death in oxidant injury to renal tubular epithelial cells", J Clin Invest, 90, pp.2593~2597 (1992)
  14. Zhang X, "Reactive oxygen species and extracellular signal-regulated kinase 1", 2 mitogen-activated protein kinase mediate hyperoxia-induced apoptosis in lung epithelium, 2003, pp.28, 305~315
  15. Pagano A, "Alveolar cell death in hyperoxia- induced lung injury", Ann N Y Acad Sci, 1010, pp.405~416 (2003)
  16. Coalson JJ, "Pathology of new bronchopulmonary dysplasia", Semin Neonatol, 8, pp.73~81 (2003)
  17. Coalson JJ, "Pathology of bronchopulmonary dysplasia", Semin Perinatol, 30, pp.179~184 (2006)
  18. Petrache I, "Mitogen-activated protein kinase pathway mediates hyperoxia-induced apoptosis in cultured macrophage cells", Am J Physiol, 277, pp.L589~L595 (1999)
  19. Kazzaz JA, "Cellular oxygen toxicity. Oxidant injury without apoptosis", J Biol Chem, 271, pp.15182~15186 (1996)
  20. Otterbein LE, "Pulmonary apoptosis in aged and oxygen-tolerant rats exposed to hyperoxia", Am J Physiol, 275, pp.L14~L20 (1998)
  21. MaGrath-Morrow SA, "Apoptosis in neonatal murine lung exposed to hyperoxia", Am J Respir Cell Mol Biol, 25, pp.150~155 (2001)
  22. Kroemer G, "The mitochondrial death", life regulator in apoptosis and necrosis, 1998, pp.60, 619~642
  23. Saraste A, "Morphologic and biological hallmarks of apoptosis", Cardiovasc Res, 45, pp.528~537 (2000)
  24. 이현수, "Effect of Short-term Exposure of Different Concentrations of Hyperoxia on Fetal Alveolar Type II Cell Death", Neonatal medicine, 20(2), pp.199~206 (2013), 대한신생아학회
  25. Bustani P, "Differential response of the epithelium and interstitium in developing human fetal lung explants to hyperoxia", Pediatr Res, 59, pp.383~388 (2006)
  26. Scavo LM, "Apoptosis in the development of rat and human fetal lungs", Am J Respir Cell Mol Biol, 18, pp.21~31 (1998)
  27. Martin TR, "Apoptosis and epithelial cell injury in the lungs", Proc Am Thorac Soc, 2, pp.214~220 (2005)
  28. Hyeon-Soo Lee, "Cathepsin B is activated as an executive protease in fetal rat alveolar type II cells exposed to hyperoxia", Experimental and Molecular Medicine, 43(4), pp.223~229 (2011), 생화학분자생물학회
  29. Hyeon-Soo Lee, "Interleukin-10 Down-Regulates Cathepsin B Expression in Fetal Rat Alveolar Type II Cells Exposed to Hyperoxia", Yonsei Medical Journal, 54(2), pp.445~452 (2013), 연세대학교의과대학
  30. Martinou JC, "Breaking the mitochondrial barrier", Nat Rev Mol Cell Biol, 2, pp.63~67 (2001)
  31. Antonsson B, "Bax oligomerization is required for channel-forming activity in liposomes and trigger cytochrome c release from mitochondria", Biochem J, 345, pp.271~278 (2000)
  32. Lemasters JJ, "The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy", Biochem Biophys Acta, 1366, pp.177~196 (1998)
  33. Layton GT, "Therapeutic effects of cysteine protease inhibition in allergic lung inflammation: inhibition of allergic-specific T lymphocyte migration", Inflamm Res, 50, pp.400~408 (2001)
  34. Bröker LE, "Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells", Cancer Res, 64, pp.27~30 (2004)
  35. Tang PS, "Lipopolysaccharide accelerates caspase-independent but cathepsin B-dependent death of human lung epithelial cells", J Cell Physiol, 209, pp.457~467 (2006)
  36. Roberg K, "Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress", Free Radic Biol Med, 27, pp.1228~1237 (1999)
  37. Roberg K, "Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuring apoptosis in neonatal rat cardiomyocytes", Am J Pathol, 152, pp.1151~1156 (1998)
  38. Guicciardi ME, "Lysosomes in cell death", Oncogene, 23, pp.2881~2890 (2004)
  39. Zhao M, "Lysosomal enzyme promotes mitochondrial oxidant production, cytochrome c release and apoptosis", Eur J Biochem, 270, pp.3778~3786 (2003)
  40. Zhao M, "Delayed oxidant-induced cell death involves activation of phospholipases A2", FEBS Lett, 509, pp.399~404 (2001)
  41. Suzuki YJ, "Oxidants as stimulators of signal transduction", Free Radic Biol Med, 22, pp.269~285 (1997)
  42. Smolen JE, "Human neutrophils permeabilized with digitonin respond with lysosomal enzyme release when exposed to micromolar levels of free calcium", Biochem Biophys Acta, 886, pp.1~17 (1986)
  43. Lee HS, "Effect of recombinant IL-10 on cultured fetal rat alveolar type II cells exposed to 65%-hyperoxia", Respir Res, 12, pp.68~ (2011)
  44. Huang B, "Neuropeptide substance P attenuates hyperoxia-induced oxidative stress injury in type II alveolar epithelial cells via suppressing the activation of JNK pathway", Lung, 187, pp.421~426 (2009)
  45. Alphonse RS, "Activation of Akt protects alveoli from neonatal oxygeninduced lung injury", Am J Respir Cell Mol Biol, 44, pp.146~154 (2011)
  46. Esquibies AE, "VEGF attenuates hyperoxic injury through decreased apoptosis in explanted rat embryonic lung", Pediatr Res, 63, pp.20~25 (2008)
  47. Mossman BT, "Introduction to serial reviews on the role of reactive oxygen and nitrogen species (ROS", RNS) in lung injury and diseases, 2003, pp.34, 1115~1116
  48. Maniscalo WM, "Hyperoxic lung injury decreases alveolar epithelial cell exposure of vascular endothelial growth factor (VEGF) in neonatal lung", Am J Respir Cell Mol Biol, 16, pp.557~567 (1997)
  49. Been JV, "Early alterations of growth factor patterns in bronchoalveolar lavage fluid from preterm infants developing bronchopulmonary dysplasia", Pediatr Res, 67, pp.83~89 (2010)
  50. Gebb SA, "Tissue interactions mediate early events in pulmonary vasculogenesis", Dev Dyn, 217, pp.159~169 (2000)
  51. Voelkel NF, "Vascular endothelial growth factor in the lung", Am J Physiol Lung Cell Mol Physiol, 290, pp.L209~L221 (2006)
  52. Watkins RH, "Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury", Am J Physiol, 276, pp.L858~L867 (1999)
  53. Guthmann F, "Inhibition of TNFalpha in vivo prevents hyperoxiamediated activation of caspase 3 in type II cells", Respir Res, 6, pp.10~ (2005)
  54. Kühn R, "Interleukin- 10-deficient mice develop chronic enterocolitis", Cell, 75, pp.263~274 (1993)
  55. Tedgui A, "Anti-inflammatory mechanisms in the vascular wall", Circ Res, 88, pp.877~887 (2001)
  56. Van Der Meeren A, "Differential regulation by IL-4 and IL-10 of radiationinduced IL-6 and IL-8 production and ICAM-1 expression by human endothelial cells", Cytokine, 11, pp.831~838 (1999)
  57. Selzman CH, "Interleukin-10 inhibits postinjury tumor necrosis factor-mediated human vascular smooth muscle proliferation", J Surg Res, 80, pp.352~356 (1998)
  58. Riley JK, "Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action", J Biol Chem, 274, pp.16513~16521 (1999)
  59. Lee HS, "Induction of IL-10 receptors and its signaling pathway in cultured fetal rat alveolar type II cells exposed to hyperoxia", Program and Abstract, The 8th Congress of Asian Society for Pediatric Research, APSR, 270 (2012), Asian Society for Pediatric Research
  60. Riyazi N, "The role of interleukin-10 promoter polymorphisms in the susceptibility of distal interphalangeal osteoarthritis", J Rheumatol, 32, pp.1571~1575 (2005)

관련 논문AI추천

이 간행물의 다른 논문 (17건)